Secondary Logo

Journal Logo

February 2021 - Volume 44 - Issue 2
pp: 45-91

Education


Central Nervous System


Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial

Elinzano, Heinrich; Toms, Steven; Robison, Jordan; More

American Journal of Clinical Oncology. 44(2):49-52, February 2021.

Gynecologic


Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy

Gaber, Germaine; El Achy, Samar; Khedr, Gehan A.; More

American Journal of Clinical Oncology. 44(2):58-67, February 2021.

Gastrointestinal


Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody

Akce, Mehmet; Liu, Yuan; Zakka, Katerina; More

American Journal of Clinical Oncology. 44(2):74-81, February 2021.

Cutaneous


Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status

van Breeschoten, Jesper; Wouters, Michel W.J.M; de Wreede, Liesbeth C.; More

American Journal of Clinical Oncology. 44(2):82-89, February 2021.